Q atar Foundation established Qatar National Research Fund (QNRF) in 2006 as part of its ongoing commitment to establish Qatar as a knowledge-based economy. Qatar Foundation views research as essential to national and regional growth; as the means to diversify the nation’s economy, enhance educational offerings and develop areas that affect the community, such as health and environment. 

Qatar National Research Fund aims to foster original, competitively selected research in More...


  • Time Zone: Arabia Time Zone UTC+03:00
  • Address: PO Box 5825, Doha, Qatar

أنشأت مؤسسة قطر الصندوق القطري لرعاية البحث العلمي عام 2006 كجزء من التزامها المستمر بإقامة الاقتصاد القائم على المعرفة في دولة قطر. وتولي مؤسسة قطر للبحوث أهمية قصوى استنادًا إلى دورها الحيوي في تحقيق النمو سواء داخل قطر أو على الصعيد الإقليمي، وكونها وسيلة لتنويع اقتصاد البلاد، وتعزيز الفرص التعليمية، وتطوير المجالات المؤثرة في المجتمع كالصحة والبيئة.

ويهدف الصندوق القطري لرعاية البحث العلمي إلى تشجيع الأبحاث المبتكرة المختارة على أساس تنافسي في

المزيد ...

  • التوقيت: توقيت غرينتش +3
  • صندوق البريد: 5825 الدوحة, قطر
  • فاكس: 8079 4454 974
  • الدعم الفني:
  • الموقع الالكتروني:

Tuesday, November 28, 2023 6:28 PM Doha Time

Research Outcome Seminar (ROS) on Precision Medicine
/ Categories: Announcements

Research Outcome Seminar (ROS) on Precision Medicine

Qatar National Research Fund (QNRF), a member of Qatar Foundation, cordially invites you to its Research Outcome Seminar (ROS) entitled, “Precision Medicine.”

Qatar is one of the first nations in the Middle East to adopt, promote, and develop precision medicine research. Moreover, Qatar is one of the few countries worldwide that has launched advanced genome projects including the Qatar Genome Programme (QGP) and Qatar Biobank (QBB). In line with the Qatar National Research Strategy, QNRF has developed and launched a special research program, “Path towards Precision Medicine (PPM),” to support, utilize, and capitalize on the resources of QGP and QBB.

The PPM aims to support and advance research that provides medical treatment tailored to the individual characteristics of each patient in Qatar based on their genetic profile to improve healthcare quality and reduce unnecessary diagnostic testing and therapies.

This ROS aims to highlight the major achievements and progress in precision medicine research in Qatar and stimulate the knowledge-sharing process by providing an interactive platform for researchers to share their outcomes. Join us to learn about exceptional research findings that explain the correlation between disease phenotype and genotype; explore the potential of translating the research findings into medical products for better healthcare, and promote a better understanding of personalized medicine among healthcare providers and the local community in Qatar.

•           The time: 10am – 12pm (Doha time)

•           The date: Thursday, 03 December 2020

•           The place: Virtual event

We look forward to seeing you there!

Please click here to join us for the live event.




10:00 to 10:10

Opening & Welcome

Dr. Mohammed Hussein Jarrar, Senior Program Manager, QNRF

10:10 to 10:25

Keynote: “Qatar Genome and its role in Precision Medicine”

Dr. Said I. Ismail, Genome Programme Director, Qatar Genome Programme

10:25 to 10:40

“Precision Medicine in Congenital Muscular Dystrophy and Neuromuscular Disorders: The Present and Future in Qatar”

Dr. Alice Abdel Aleem, Weill Cornell Medicine - Qatar

Project Number:  PPM1-1206-150013

10:40 to 10:55

“Genetic VERSUS Environmental Basis for Familial Diabetes in Qatar”

Prof. Abdul-Badi Abou-Samra, Professor of Medicine Director, Qatar Metabolic Institute Chief Quality Officer and Deputy CMO, Hamad Medical Corporation

Project Number: PPM1-0102-160028

10:55 to 11:10

“Rational Metabolic Engineering as a New Tool for Targeted Intervention in Human Metabolism”

Prof. Karsten Suhre, Professor of Physiology and Biophysics and Dr. Anna Maria Halama, Weill Cornell Medicine - Qatar

Project Number: NPRP8-061-3-011

11:10 to 11:25

“A high-resolution map of structural variation in Qatari genomes and their contribution to quantitative traits and disease”

Dr. Khalid Fakhro, Investigator, Sidra Medicine

Project PPM1-1229-150022 and NPRP11S-0110-180250

11:25 to 11:40

“Saliva diagnostics to pave the way towards personalized medicine”

Dr. Souhaila Al Khodor, Director of Maternal and Child Health Program, Sidra Medicine

Project Number: PPM2-0216-170012

11:40 to 11:55

Q & A Session

11:55 to 12:00

Concluding Remarks

Previous Article WCM-Q scientists produce WHO report on eliminating hepatitis C in Eastern Mediterranean region
Next Article QNRF and TÜBİTAK Announce Results for the Smart Cities Call
«November 2023»